Home/Filings/4/0001493152-22-004718
4//SEC Filing

Hogge Gary S. 4

Accession 0001493152-22-004718

CIK 0000876343other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 7:42 PM ET

Size

5.6 KB

Accession

0001493152-22-004718

Insider Transaction Report

Form 4
Period: 2022-02-11
Hogge Gary S.
SVP,Clinical & Medical Affairs
Transactions
  • Award

    Restricted Stock Units

    2022-02-11+52,08152,081 total
    Common Shares (52,081 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.
  • [F2]Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

Documents

1 file

Issuer

Lineage Cell Therapeutics, Inc.

CIK 0000876343

Entity typeother

Related Parties

1
  • filerCIK 0001771711

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 7:42 PM ET
Size
5.6 KB